An ageing population and the need for more specific tissue analysis create an increasing demand for improved analytical methods, with the potential for digital analysis and automation. Lumito creates technology that makes this possible.

Lumito’s business concept is to create high quality images of tissue based on proprietary and patented technology, with UCNP as a marker.

The level of accuracy based on today’s staining methods in tissue diagnostics is limited, which means that pathologists’ opinions are in risk of being incorrect or uncertain, which emphasises a strong need for increased accuracy.